345 related articles for article (PubMed ID: 28380678)
21. Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate-associated large B lymphoproliferative disorders.
Yamada K; Oshiro Y; Okamura S; Fujisaki T; Kondo S; Nakayama Y; Suematsu E; Tamura K; Takeshita M
Histopathology; 2015 Jul; 67(1):70-80. PubMed ID: 25429725
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics of methotrexate-associated lymphoproliferative disorders: relationship between absolute lymphocyte count recovery and spontaneous regression.
Takanashi S; Aisa Y; Ito C; Arakaki H; Osada Y; Amano Y; Hirano M; Nakazato T
Rheumatol Int; 2017 Oct; 37(10):1629-1633. PubMed ID: 28676912
[TBL] [Abstract][Full Text] [Related]
23. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
Omameuda T; Miyato H; Sata N; Lefor AK
Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics and incidence of methotrexate-related lymphoproliferative disorders of patients with rheumatoid arthritis.
Yoshida Y; Takahashi Y; Yamashita H; Kano T; Kaneko H; Mimori A
Mod Rheumatol; 2014 Sep; 24(5):763-5. PubMed ID: 24498893
[TBL] [Abstract][Full Text] [Related]
26. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
Kitamura N; Sugiyama K; Nagasawa Y; Hamaguchi M; Kobayashi H; Takei M
Clin Exp Rheumatol; 2022 Jul; 40(7):1330-1335. PubMed ID: 34369356
[TBL] [Abstract][Full Text] [Related]
27. Prognostic factors of methotrexate-associated lymphoproliferative disorders associated with rheumatoid arthritis and plausible application of biological agents.
Katsuyama T; Sada KE; Yan M; Zeggar S; Hiramatsu S; Miyawaki Y; Ohashi K; Morishita M; Watanabe H; Katsuyama E; Takano-Narazaki M; Toyota-Tatebe N; Sunahori-Watanabe K; Kawabata T; Miyake K; Kiguchi T; Wada J
Mod Rheumatol; 2017 Sep; 27(5):773-777. PubMed ID: 27846761
[TBL] [Abstract][Full Text] [Related]
28. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases.
Satou A; Tabata T; Suzuki Y; Sato Y; Tahara I; Mochizuki K; Oishi N; Takahara T; Yoshino T; Tsuzuki T; Nakamura S
Virchows Arch; 2021 May; 478(5):969-976. PubMed ID: 33169195
[TBL] [Abstract][Full Text] [Related]
29. Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin-associated large B-cell lymphoma-like lesions in aortic and mitral valves.
Tsujii H; Nakayama R; Funakoshi S; Tsuji S; Haga H; Ono K
Pathol Int; 2024 May; 74(5):285-291. PubMed ID: 38563592
[TBL] [Abstract][Full Text] [Related]
30. Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report.
Kikuchi N; Uesugi M; Koda M; Shimizu T; Murakami K; Kono M; Tanaka H; Yamazaki M
J Neurosurg Spine; 2018 Nov; 29(5):545-548. PubMed ID: 30168781
[TBL] [Abstract][Full Text] [Related]
31. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders.
Yamakawa N; Fujimoto M; Kawabata D; Terao C; Nishikori M; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Ohmura K; Fujii T; Kitano T; Kondo T; Yurugi K; Miura Y; Maekawa T; Saji H; Takaori-Kondo A; Matsuda F; Haga H; Mimori T
J Rheumatol; 2014 Feb; 41(2):293-9. PubMed ID: 24334644
[TBL] [Abstract][Full Text] [Related]
32. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases.
Salloum E; Cooper DL; Howe G; Lacy J; Tallini G; Crouch J; Schultz M; Murren J
J Clin Oncol; 1996 Jun; 14(6):1943-9. PubMed ID: 8656264
[TBL] [Abstract][Full Text] [Related]
33. Retrospective analyses of other iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with rheumatic diseases.
Kaji D; Kusakabe M; Sakata-Yanagimoto M; Makishima K; Suehara Y; Hattori K; Ota Y; Mitsuki T; Yuasa M; Kageyama K; Taya Y; Nishida A; Ishiwata K; Takagi S; Yamamoto H; Asano-Mori Y; Ubara Y; Izutsu K; Uchida N; Wake A; Taniguchi S; Yamamoto G; Chiba S
Br J Haematol; 2021 Nov; 195(4):585-594. PubMed ID: 34558064
[TBL] [Abstract][Full Text] [Related]
34. Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients.
Saito S; Takeuchi T
J Clin Exp Hematop; 2019; 59(4):145-155. PubMed ID: 31866617
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate-associated Lymphoproliferative Disorder of the Stomach Presumed to Be Mucosa-associated Lymphoid Tissue Lymphoma.
Ishigaki S; Masaoka T; Kameyama H; Kawaida M; Kameyama K; Mori T; Kanai T
Intern Med; 2018; 57(22):3249-3254. PubMed ID: 30429434
[TBL] [Abstract][Full Text] [Related]
36. A case of rheumatoid arthritis with methotrexate related lymphoproliferative diseases of the knee.
Abe A; Wakaki K; Ishikawa H; Ito S; Murasawa A
Mod Rheumatol; 2018 May; 28(3):550-554. PubMed ID: 26558294
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous Regression of Methotrexate-related Lymphoproliferative Disorder with T-cell Large Granular Lymphocytosis.
Ureshino H; Kadota C; Kurogi K; Miyahara M; Kimura S
Intern Med; 2015; 54(17):2235-9. PubMed ID: 26328653
[TBL] [Abstract][Full Text] [Related]
38. Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate.
Saito S; Kaneko Y; Yamaoka K; Tokuhira M; Takeuchi T
Rheumatology (Oxford); 2017 Jun; 56(6):940-946. PubMed ID: 28165538
[TBL] [Abstract][Full Text] [Related]
39. [Three cases of methotrexate-associated lymphoproliferative disorder (MTX-LPD)].
Ishida Y; Asahi A; Wada T; Kanai N; Kobayashi Y; Moriai S; Kishibe K; Harabuchi Y
Nihon Jibiinkoka Gakkai Kaiho; 2008 Aug; 111(8):594-8. PubMed ID: 18788425
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate-associated lymphoproliferative disorder with histopathological features of histiocytic necrotizing lymphadenitis.
Kaito S; Goto M; Iguchi M; Okuno Y; Moriyoshi K; Koyama H
Mod Rheumatol Case Rep; 2021 Jan; 5(1):141-144. PubMed ID: 33269654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]